CONSULTING AGREEMENTConsulting Agreement • January 23rd, 2013 • Oxigene Inc • Biological products, (no disgnostic substances) • California
THIS CONSULTING AGREEMENT (“Agreement”) is made effective as of January __, 2013 (the “Effective Date”) by and between OXiGENE, Inc., a Delaware corporation (“OXiGENE”), with offices at 701 Gateway Blvd., South San Francisco, CA 94080 and David Chaplin, Ph.D. (“CONSULTANT”), having a principal place of business at 14 Plowden Park, Aston Rowant, Watlington, Oxfordshire, OX49 5SX, UK. (OXiGENE and CONSULTANT may be referred to individually as a “Party” or collectively as the “Parties.”)
